A Double‐blind Crossover Trial of Baclofen—a New Treatment for the Unstable Bladder Syndrome

Abstract

Forty patients with the unstable bladder syndrome have been treated in a double-blind crossover trial of baclofen 5 mg qds versus placebo. Baclofen significantly improved diurnal and nocturnal frequency of micturition and the severity of incontinence. Considerable improvement was also obtained with placebo.